Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review

BACKGROUND: Diabetic nephropathy (DN) is the main cause of chronic kidney disease and end-stage renal disease worldwide. Although available clinical trials have shown that endothelin receptor (ER) antagonists may be a novel and beneficial drug for DN, no consistent conclusions regarding their suffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Xue, Shuai, Hou, Jie, Chen, Guang, Xu, Zhong-Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672789/
https://www.ncbi.nlm.nih.gov/pubmed/33269066
http://dx.doi.org/10.4239/wjd.v11.i11.553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672789/
https://www.ncbi.nlm.nih.gov/pubmed/33269066
http://dx.doi.org/10.4239/wjd.v11.i11.553

Ejemplares similares